Oleg is 13 years old. The boy felt unwell in the summer of 2006, during training at a summer sports camp. His right leg ached, and acute pains appeared in his back. After an examination, a terrible diagnosis was pronounced: neuroectodermal tumor of the small pelvis with growth into the spinal canal, stage 3. The boy's condition deteriorated day after day. The pains became worse, and the boy couldn't step on this leg. Only strong analgesics helped. He walked only on crutches.
Three weeks later, in September, Oleg had a serious operation at the Burdenko Institute of Neurosurgery in Moscow. A small part of the tumor was removed from the spine, but the major part remained.
Oleg has already spent 4 months at the Department of Oncology, RCCH. He has gone through six cycles of severe chemotherapy. His condition has improved to some extent, and the pains are not so strong.
Doctors of the Munich hospital have agreed to take Oleg for treatment and to perform another serious surgery: removal of the remaining part of the tumor. The boy's condition requires immediate surgical intervention at the moment when remission is attained, while the growth of tumor cells is blocked by the chemotherapy. The surgery costs quite a lot: 30,000 euro, according to the account from the Munich clinic.
Oleg's parents Eugenia and Igor ask for help. They address everybody who can help Oleg become a healthy boy again, live and smile just like all children, study and indulge in sports.

The doctor's comment

The patient's condition shows slight positive dynamics regarding the primary tumor after partial oncotomy and six cycles of polychemotherapy. Presently it is appropriate to perform surgery with maximum possible removal of the tumor, for both diagnostic and curative purposes. Considering the complex localization of the tumor and its dissemination, surgical intervention with the best result is possible at a foreign hospital. The Munich University Surgical Clinic (Germany) has agreed to perform the surgery. It should be conducted in three or four weeks after the last cycle of polychemotherapy, that is, on February 26-28, 2007.

Federal Center for Pediatric Hematology, Oncology, and Immunology,
Head of the Department of Neurooncology
Prof. O.G. Zheludkova

Donate on-line